The Pharmacokinetics of Flucytosine in Cryptococcal Meningitis

Wade D. N. Sudlow G. : The Kinetics of 5-Fluorocytosine Elimination in Man, Aust. N. Z. J. Med., 2: 153–158 (May) 1972.

Seneca H. : Biological Basis of Chemotherapy of Infections and Infestations, F. A. Davis Co., Philadelphia, Pa., 1971, pp 519–524.

Wintrobe M. M. : Harrison's Principles of Internal Medicine, 6th ed., McGraw-Hill Book Co., New York, N.Y., 1970, pp. 908–909.

Kagan B. M. : Antimicrobial Therapy, W. B. Saunders Co., Philadelphia, Pa., 19105, 1970, pp 250–251.

Hillier W. F. Shanklin J. R. : Cryptococcus Meningitis (Report of a case with successful treatment), West Virginia Med. J., 61: 133–138 (June) 1965.

Witorsch P. : Intravenous Administration of Amphotericin B. Use of Subcutaneous Reservoir in Four Patients with Mycotic Meningitis, J. Am. Med. Assoc. 194: 699–702 (Nov. 15) 1965.

Chomicki J. : Coexistence of Pulmonary Tuberculosis with Pulmonary and Meningeal Cryptococcosis. Report of a Case, Dis. Chest 50: 214–216 (Aug.) 1966.

Hess R. : Cryptococcosis: A Case Report with Review, Southwest Med. 47: 266–269 (Oct.) 1969.

Drutz D. J. : Treatment of Disseminated Mycotic Infection. A New Approach to Amphotericin B Therapy, Amer. J. Med. 45: 405–418 (Sept.) 1968.

Watkins J. S. : Two Cases of Cryptococcal Meningitis, One Treated with 5-FC, Brit. Med. J. 3: 29–31 (July 5) 1969.

Sarosi G. A. : Cutaneous Cryptococcosis. A Sentinel of Disseminated Disease, Arch. Derm. 104: 1–3 (July) 1971.

Collins J. V. : Cryptococcal Meningitis as a Complication of Systemic Lupus Erythematosus Treated with Systemic Steroid, Postgrad. Med. J. 48: 52–55, 1972.

Reichelderfer T. E. : Flucytosine Therapy in Cryptococcosis. Report of a Case, Med. Ann. D.C. 41: 622–624 (Oct.) 1972.

Bach M. C. : Influence of Rejection Therapy on Fungal and Nocardial Infections in Renal Transplant Recipients, Lancet 1: 180–184 (Jan. 27) 1973.

Sarosi G. A. : Amphotericin B in Cryptococcal Meningitis. Long Term Results of Treatment, Ann. Intern. Med. 71: 1079–1087 (Dec.) 1969.

Anon: Med. Letter Drugs Ther. 14: (Apr. 28) 1972.

Goodman L. S. Gilman A. : The Pharmacological Basis of Therapeutics, 4th ed., The Macmillan Co., New York, N. Y. 10022, 1970, pp 1300–1302.

Bindschadler D. D. Bennett J. F. : A Pharmacologic Guide to the Clinical Use of Amphotericin B, J. Infect. Dis. 120: 427–436 (Oct.) 1969.

Gonyea E. F. : Cisternal Puncture and Cryptococcal Meningitis, Arch. Neurol. 28: 200–201 (Mar.) 1973.

Bardana E. J. : Amphotericin B and Cryptococcal Infection. An Objective Method for the Evaluation of Treatment, Arch. Intern. Med. 122: 517–520 (Dec.) 1968.

Cherry J. D. : Amphotericin B Therapy in Children. A Review of the Literature and a Case Report, J. Pediat. 73: 1063–1069 (Dec.) 1969.

Philpol C. R. Lo D. : Cryptococcal Meningitis in Pregnancy, Med. J. Aust. 2: 1005–1007 (Oct. 28) 1972.

Osol A. Pratt R. : The United States Dispensatory, J. B. Lippincott Co., Philadelphia, Pa. 1973, p 115.

Utz J. P. : 5-Fluorocytosine in Human Cryptococcosis, Amtimicrob. Agents Chemother. 1968, pp 344–346.

Schönebeck J. : Pharmacokinetic Studies on the Oral Agent 5-Fluorocytosine in Individuals with Normal and Impaired Kidney Function, Chemotherapy 18: 321–336, 1973.

Fass R. J. Perkins R. L. : 5-Fluorocytosine in the Treatment of Cryptococcal and Candida Mycoses, Ann. Intern. Med. 74: 535–539 (Apr.) 1971.

Shadomy S. : In Vitro Studies with 5-Fluorocytosine, Appl. Microbiol. 17: 871–877 (June) 1969.

Holt R. J. Newman R. L. : The Antimycotic Activity of 5-Fluorocytosine, J. Clin. Pathol. 26: 167–174, 1973.

Block E. R. Bennett J. E. : Pharmacological Studies with 5-Fluorocytosine, Antimicrob. Agents Chemother. 1: 476–482 (June) 1972.

Record C. O. : Candida Endocarditis Treated with 5-Fluorocytosine, Brit. Med. J. 1: 262–264 (Jan. 30) 1971.

Atkinson W. G. Israel H. L. : 5-Fluorocytosine Treatment of Meningeal and Pulmonary Aspergillosis, Amer. J. Med. 55: 496–504 (Oct.) 1973.

Davis R. R. Reeves D. S. : 5-Fluorocytosine and Urinary Candidiasis, Brit. Med. J. 1: 577–579 (Mar. 13) 1971.

Normark S. Schonebeck J. : In Vitro and In Vivo 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrata, Antimicrob. Agents Chemother. 2: 114–121, 1972.

Dawborn J. K. : Use of 5-Fluorocytosine in Patients with Impaired Renal Function, Brit. Med. J. 4: 382–384 (Nov. 17) 1973.

Giusti D. L. Hayton W. L. : Dosage Regimen Adjustments in Renal Impairment, Drug Intell. Clin. Pharm. 7: 382–387 (Sept.) 1973.

McCollum N. : Drug Evaluation Data: Flucytosine, Drug Intell. Clin. Pharm. 7: 75–77 (Feb.) 1973.

Tassel D. Madoff M. A. : Treatment of Candida Sepsis and Cryptococcus Meningitis with 5-Fluorocytosine, J. Am. Med. Ass. 206: 830–832 (Oct. 21) 1968.

Warner J. F. : 5-Fluorocytosine in Human Candidiasis, Antimicrob. Agents Chemother. 1970, pp. 473–475.

Schonebeck J. Segerbrand E. : Candida Albicans Septicaemia During First Half of Pregnancy Successfully Treated with 5-Fluorocytosine, Brit. Med. J. 4: 337–338 (Nov. 10) 1973.

Schiavone D. J. : Rapid Microbial Assay for 5-Fluorocytosine, Brit. Med. J. 4: 380–382 (Nov. 17) 1973.

Steer P. L. : 5-Fluorocytosine: An Oral Antifungal Compound, Ann. Intern. Med. 76: 15–22 (Jan.) 1972.